Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is i...
Q1 2026
May 14, 2026
FY 2025
Mar 25, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 11, 2025